Advanced Medical Isotope Corp. (ADMD) Starts Presentation at SeeThruEquity Conference

Advanced Medical Isotope (OTC: ADMD) is a late-stage development company engaged in the development of brachytherapy devices for therapeutic applications. AMIC’s focus is on transitioning to full operations upon receipt of FDA clearance for its patented brachytherapy cancer products. Brachytherapy uses radiation to destroy cancerous tumors by placing a radioactive isotope inside or next to the treatment area. The company intends to outsource material aspects of manufacturing, distribution, sales and marketing for its products in the United States and to enter into licensing arrangements outside of the United States. For more information, visit the company’s website at www.isotopeworld.com